You are here

axalimogene filolisbac

Advaxis suffers another blow as FDA puts phase 3 on partial hold

Fierce Biotech

Thu, 01/24/19 - 10:53 am

clinical trials

axalimogene filolisbac

cervical cancer

Advaxis Shares Jump After FDA Lifts Clinical Hold on Phase 1/2 Study

CP Wire

Fri, 07/13/18 - 09:18 am

axalimogene filolisbac

HPV head and neck cancer

cervical cancer

Advaxis Shares Jump After FDA Lifts Clinical Hold on Phase 1/2 Study

Fri, 07/13/18 - 09:07 am

axalimogene filolisbac

HPV head and neck cancer

cervical cancer

Advaxis cuts staff as it seeks partner for troubled cancer vaccine

Fierce Biotech

Sun, 06/10/18 - 06:58 pm

axalimogene filolisbac

cancer vaccines

Advaxis shares drop after FDA clinical trial hold

Marketwatch

Tue, 10/6/15 - 07:10 pm

clinical trials

axalimogene filolisbac

cervical cancer

Advaxis gets a whiplash after its upbeat assessment of PhII cancer vaccine data

Fierce Biotech

Fri, 09/18/15 - 10:52 am

axalimogene filolisbac

cervical cancer